海翔药业

- 002099

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
海翔药业(002099) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入167,663.03119,644.0763,404.78270,414.40207,109.52
营业收入167,663.03119,644.0763,404.78270,414.40207,109.52
二、营业总成本165,911.89113,306.7764,212.59247,630.49179,571.39
营业成本135,196.2895,419.1350,704.50198,386.98146,242.97
营业税金及附加2,046.061,358.63606.492,127.561,540.34
销售费用2,098.071,346.87477.482,628.121,755.17
管理费用22,719.0414,481.166,824.3140,244.2933,241.43
财务费用-5,475.37-5,607.642,496.09-10,247.80-14,124.51
研发费用9,327.806,308.623,103.7314,491.3410,916.00
资产减值损失----------
公允价值变动收益-4,379.50-6,415.83926.34-1,958.41-4,820.76
投资收益-6,141.69-1,226.132,008.86-2,275.25-346.97
其中:对联营企业和合营企业的投资收益-876.66-893.09-304.44-3,297.07-984.88
汇兑收益----------
三、营业利润-4,435.801,789.784,429.9910,939.9023,600.94
加:营业外收入3.345.211.57153.3694.82
减:营业外支出140.3790.3024.501,012.94105.65
其中:非流动资产处置损失----------
四、利润总额-4,572.831,704.694,407.0610,080.3123,590.11
减:所得税费用-624.90-139.17222.161,472.502,997.92
五、净利润-3,947.931,843.874,184.898,607.8120,592.19
归属于母公司所有者的净利润-3,858.811,917.194,210.198,801.3720,711.57
少数股东损益-89.13-73.32-25.30-193.56-119.38
六、每股收益
基本每股收益(元/股)-0.02000.01000.02000.05000.1300
稀释每股收益(元/股)-0.02000.01000.02000.05000.1300
七、其他综合收益------422.36-29.35
八、综合收益总额-3,947.931,843.874,184.899,030.1720,562.84
归属于母公司所有者的综合收益总额-3,858.811,917.194,210.199,223.7320,682.22
归属于少数股东的综合收益总额-89.13-73.32-25.30-193.56-119.38
下载全部历史数据到excel中 返回页顶